January 08, 2025

Calcium Cuts Colorectal Cancer Risk by 17%, Large Study Finds

Calcium intake reduces colorectal cancer risk by 17% per 300 mg/day, with dairy sources showing the strongest associations, as revealed in a large-scale study.

Conexiant

January 06, 2025

Female Vulnerability to Alzheimer’s Linked to Unique Genetic Pathways

Neuropathology-based genetic study links disrupted lipid metabolism and immune dysfunction to Alzheimer’s.

Conexiant

December 30, 2024

Tppp3 Gene Boosts Optic Nerve Healing in Mammals, Study Finds

Researchers uncover the regenerative potential of Tppp3, a gene that enhances retinal ganglion cell survival and stimulates axon regeneration.

Conexiant

December 27, 2024

The Retina as a Window to Alzheimer’s: Study Highlights Key Microglial Changes

Using advanced machine learning, researchers examine microglial morphology in Alzheimer’s, revealing novel insights into disease mechanisms.

Conexiant

December 18, 2024

Understanding the 2022 WHO Classification of Endocrine Tumors

From the parathyroid to adrenal glands and thyroid tumors, the latest WHO classification introduces essential updates to tumor nomenclature and diagnostic criteria.

Conexiant

November 07, 2024

AI in Neuropathology: How Language Models Are Transforming Brain Tumor Diagnosis

New research explores how integrating AI with clinical guidelines can enhance diagnostic precision for complex brain tumors.

Conexiant

November 18, 2024

The Adaptive Immune System's Role in Gut Health and IBD

Researchers identified segment-specific effects of immune cells on intestinal contractions, providing new angles for managing inflammatory bowel disease.

Conexiant

September 30, 2024

New DNA Test Accurately Differentiates Between Thymic Tumors

Misdiagnosis can lead to inappropriate treatment, potentially subjecting patients to unnecessary toxicity or, conversely, inadequate treatment for a life-threatening cancer.

Conexiant

October 30, 2024

Study Identifies RUNX1 as a Major Therapeutic Target in Acute Kidney Injury

Targeting the RUNX1 pathway may reduce inflammation and improve kidney function in patients with acute kidney injury, potentially preventing the disease from progressing to chronic kidney failure.

Conexiant